DISEASE INDICATIONS: Progressive Familial Intrahepatic Cholestasis
MANUFACTURER: Albireo Pharma
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Bylvay, known by its generic name Odevixibat, is a pharmaceutical medication used to treat a rare genetic disorder known as progressive familial intrahepatic cholestasis (PFIC).